|
nasdaq:trvn
|
244599
|
Apr 21st, 2024 12:00AM
|
Trevena, Inc.
|
5.6K
|
35.00
|
Open
|
|
Apr 21st, 2024 03:22AM
|
Apr 21st, 2024 03:22AM
|
Trevena is a biopharmaceutical company focused on developing and commercializing novel medicines for patients with central nervous system (CNS) disorders.
|
Open
|
drug discovery & development, GPCRs, pain medicine, acute care medicine, and CNS Disorders
|
Open
|
955 Chesterbrook Blvd
|
Chesterbrook
|
Pennsylvania
|
US
|
19087
|
|
Trevena
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:trvn
|
244599
|
Apr 20th, 2024 12:00AM
|
Trevena, Inc.
|
5.6K
|
35.00
|
Open
|
|
Apr 20th, 2024 12:15AM
|
Apr 20th, 2024 05:45PM
|
Trevena is a biopharmaceutical company focused on developing and commercializing novel medicines for patients with central nervous system (CNS) disorders.
|
Open
|
drug discovery & development, GPCRs, pain medicine, acute care medicine, and CNS Disorders
|
Open
|
955 Chesterbrook Blvd
|
Chesterbrook
|
Pennsylvania
|
US
|
19087
|
|
Trevena
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:trvn
|
244599
|
Apr 19th, 2024 12:00AM
|
Trevena, Inc.
|
5.6K
|
35.00
|
Open
|
|
Apr 19th, 2024 04:45AM
|
Apr 19th, 2024 04:45AM
|
Trevena is a biopharmaceutical company focused on developing and commercializing novel medicines for patients with central nervous system (CNS) disorders.
|
Open
|
drug discovery & development, GPCRs, pain medicine, acute care medicine, and CNS Disorders
|
Open
|
955 Chesterbrook Blvd
|
Chesterbrook
|
Pennsylvania
|
US
|
19087
|
|
Trevena
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:trvn
|
244599
|
Apr 18th, 2024 12:00AM
|
Trevena, Inc.
|
5.6K
|
35.00
|
Open
|
|
Apr 18th, 2024 01:24AM
|
Apr 18th, 2024 07:05PM
|
Trevena is a biopharmaceutical company focused on developing and commercializing novel medicines for patients with central nervous system (CNS) disorders.
|
Open
|
drug discovery & development, GPCRs, pain medicine, acute care medicine, and CNS Disorders
|
Open
|
955 Chesterbrook Blvd
|
Chesterbrook
|
Pennsylvania
|
US
|
19087
|
|
Trevena
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:trvn
|
244599
|
Apr 17th, 2024 12:00AM
|
Trevena, Inc.
|
5.6K
|
35.00
|
Open
|
|
Apr 17th, 2024 04:19AM
|
Apr 17th, 2024 03:32PM
|
Trevena is a biopharmaceutical company focused on developing and commercializing novel medicines for patients with central nervous system (CNS) disorders.
|
Open
|
drug discovery & development, GPCRs, pain medicine, acute care medicine, and CNS Disorders
|
Open
|
955 Chesterbrook Blvd
|
Chesterbrook
|
Pennsylvania
|
US
|
19087
|
|
Trevena
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:trvn
|
244599
|
Apr 16th, 2024 12:00AM
|
Trevena, Inc.
|
5.6K
|
35.00
|
Open
|
|
Apr 16th, 2024 12:05AM
|
Apr 16th, 2024 11:48AM
|
Trevena is a biopharmaceutical company focused on developing and commercializing novel medicines for patients with central nervous system (CNS) disorders.
|
Open
|
drug discovery & development, GPCRs, pain medicine, acute care medicine, and CNS Disorders
|
Open
|
955 Chesterbrook Blvd
|
Chesterbrook
|
Pennsylvania
|
US
|
19087
|
|
Trevena
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:trvn
|
244599
|
Apr 15th, 2024 12:00AM
|
Trevena, Inc.
|
5.6K
|
35.00
|
Open
|
|
Apr 15th, 2024 12:00AM
|
Apr 15th, 2024 05:29PM
|
Trevena is a biopharmaceutical company focused on developing and commercializing novel medicines for patients with central nervous system (CNS) disorders.
|
Open
|
drug discovery & development, GPCRs, pain medicine, acute care medicine, and CNS Disorders
|
Open
|
955 Chesterbrook Blvd
|
Chesterbrook
|
Pennsylvania
|
US
|
19087
|
|
Trevena
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:trvn
|
244599
|
Apr 14th, 2024 12:00AM
|
Trevena, Inc.
|
5.6K
|
35.00
|
Open
|
|
Apr 13th, 2024 11:49PM
|
Apr 13th, 2024 11:49PM
|
Trevena is a biopharmaceutical company focused on developing and commercializing novel medicines for patients with central nervous system (CNS) disorders.
|
Open
|
drug discovery & development, GPCRs, pain medicine, acute care medicine, and CNS Disorders
|
Open
|
955 Chesterbrook Blvd
|
Chesterbrook
|
Pennsylvania
|
US
|
19087
|
|
Trevena
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:trvn
|
244599
|
Apr 13th, 2024 12:00AM
|
Trevena, Inc.
|
5.6K
|
35.00
|
Open
|
|
Apr 12th, 2024 11:40PM
|
Apr 13th, 2024 12:14PM
|
Trevena is a biopharmaceutical company focused on developing and commercializing novel medicines for patients with central nervous system (CNS) disorders.
|
Open
|
drug discovery & development, GPCRs, pain medicine, acute care medicine, and CNS Disorders
|
Open
|
955 Chesterbrook Blvd
|
Chesterbrook
|
Pennsylvania
|
US
|
19087
|
|
Trevena
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:trvn
|
244599
|
Apr 12th, 2024 12:00AM
|
Trevena, Inc.
|
5.6K
|
35.00
|
Open
|
|
Apr 11th, 2024 11:47PM
|
Apr 12th, 2024 09:10AM
|
Trevena is a biopharmaceutical company focused on developing and commercializing novel medicines for patients with central nervous system (CNS) disorders.
|
Open
|
drug discovery & development, GPCRs, pain medicine, acute care medicine, and CNS Disorders
|
Open
|
955 Chesterbrook Blvd
|
Chesterbrook
|
Pennsylvania
|
US
|
19087
|
|
Trevena
|
Health Care
|
Pharmaceuticals & Biotechnology
|